Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

G Louis Lange

Affiliations

  • Director at Audentes Therapeutics Inc. (BOLD), 2019-03-27
  • Director at Cymabay Therapeutics Inc. (CBAY), 2015-06-30
  • Director at Esperion Therapeutics Inc. (ESPR), 2013-07-01
  • Director at Maxygen Inc (MAXY), 2012-06-07
  • Officer, Director at Cv Therapeutics Inc (CVTX), 2009-04-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ESPR $14.00 10,714 Director 197,703 2013-07-01 Filing
ESPR $14.00 3,500 Director 17,814 2013-07-01 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BOLD $35.94 558 Director 0 2019-03-25 Filing
BOLD $36.00 1,000 Director 16,678 2019-03-25 Filing
BOLD $36.64 300 Director 305,799 2019-03-25 Filing
BOLD $35.99 19,700 Director 306,099 2019-03-25 Filing
BOLD $18.50 10,000 Director 32,343 2018-12-24 Filing